Actavis Nifedipine Capsules Recall: Foreign Tablets in Product
Actavis recalls 100-count Nifedipine capsules due to foreign tablets. Consumers should contact the company for details on affected lots.
Lower-risk recall
Presence of Foreign Tablets/Capsules
Contact the company
What happened, in plain English
Actavis is recalling 100-count Nifedipine capsules (10 mg, Rx only) because foreign tablets may be present. This could lead to unintended medication intake if the capsules are taken without proper identification. Read more at govinfonow.com/recall/42298-actavis-nifedipine-capsules-recall-foreign-tablets-in-product.
Source Summary by GovInfoNow · govinfonow.com/recall/42298-actavis-nifedipine-capsules-recall-foreign-tablets-in-product · Updated October 9, 2026 · FDA enforcement record: FDA #D-0143-2017
Cite this page
“Actavis Nifedipine Capsules Recall: Foreign Tablets in Product.” GovInfoNow, updated October 9, 2026. https://govinfonow.com/recall/42298-actavis-nifedipine-capsules-recall-foreign-tablets-in-product. Based on FDA recall #D-0143-2017 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0143-2017%22&limit=1).
Why it’s dangerous
Foreign tablets can be present in the capsules, which may lead to unintended medication intake if the capsules are taken without proper identification. This could cause incorrect dosing or adverse effects.
Who’s affected
People who have the specific 100-count Nifed:ipine capsules with lot number 0598B151 from Actavis Elizabeth LLC. Those who take the capsules without checking for foreign tablets are at higher risk.
How to tell if you have this one
Check for the product name 'Nifedipine Capsules USP, 10 mg, Rx only', 100 count bottle, and lot number 0598B151 on the label. The product was distributed by Actavis Elizabeth LLC in Elizabeth, NJ.
- Brand
Actavis- Category
Drug
What to do — step by step
Check Product Label
Look for the lot number 0598B151 on the capsule bottle to confirm if it's affected.
How this recall unfolded
Recall timeline
FDA terminated this recall 7 months after the firm started it.
- Firm started the recall
- FDA classified it Class III
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Similar recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0143-2017 (October 6, 2016) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0143-2017 to see it in context.
- Plain-language summary written by qwen3:4b on October 9, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.